SecBot SecBot
SC 13G/A ·Filed Oct 29, 2026

ARCT

Arcturus Therapeutics Holdings Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3d 17h ago SEC0001214659-26-013368
Passive stake amendment
Actionable Insight • Neutral

The incremental increase is immaterial; monitor future 13G filings for any trend of accumulation or reduction. No immediate catalyst from this passive stake update.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled: T+1d
ARCT ▼ -9.22% at T+1d
NEUTRAL call -9.22% · α vs SPY -7.45% · entry $12.15 → $11.03
Next anchor: T+5d in 3d
Entry = T+0 close
Oct 29, 2026
via day close
T+1d
-9.22%
call -9.22% · α -7.45%
$11.03
settled 3d ago
T+5d
Pending
in 3d
T+20d
Pending
in 25d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Sumitomo Mitsui Trust Group, Inc. filed an amended Schedule 13G disclosing beneficial ownership of 1,689,107 shares of Arcturus Therapeutics common stock, representing 5.9% of shares outstanding as of September 30, 2026. This is a routine passive stake update; the stake increased slightly from 1,678,069 shares (5.90%) reported in the prior October 7, 2026 filing, representing a net addition of approximately 11,038 shares. The filing reaffirms passive investment intent with no activist implications.

Key Financial Metrics

Stake
5.9%
Investor
Sumitomo Mitsui Trust Group, Inc.

Key Facts

  • Sumitomo Mitsui Trust Group disclosed 1,689,107 shares (5.9%) as of September 30, 2026
  • The stake increased by approximately 11,038 shares from the prior filing (1,678,069 shares, 5.90%)
  • Filing is a routine passive 13G amendment with no activist intent
  • Amova Asset Management Co., Ltd. is the investment adviser subsidiary holding the shares

Financial Impact

Stake valued at approximately $18.8M based on $319M market cap and 5.9% ownership

ownership_percentage

Risk Factors

  • No material risks identified from this routine passive filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
84% bullish (19 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001214659-26-013368
Document: 0001214659-26-013368-index.html0001214659-26-013368
Document: 0001214659-26-013368.txt0001214659-26-013368
6 reports for ARCT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ARCT, sortable and filterable
TypeNow
Oct 29, 2026
3d ago
SC 13G/A
NEUTRAL ★ 2/10
$12.15awaiting T+20awaiting T+20$11.03 (−9.22%)
Oct 7, 2026
25d ago
SC 13G/A
NEUTRAL ★ 3/10
$12.77awaiting T+20awaiting T+20$11.03 (−13.59%)
Sep 28, 2026
5w ago
Court Ruling
NEUTRAL ★ 2/10
$13.70 $10.81▼ −21.09%▼ −21.76%$11.03 (−19.49%)
Aug 25, 2026
9w ago
8-K
NEUTRAL ★ 3/10
$15.44 $14.69▼ −4.86%▼ −6.10%$11.03 (−28.56%)
Aug 15, 2026
11w ago
Institutional Cluster
BULLISH ★ 5/10
$8.14 $15.84▲ +94.59%▲ +96.57%$11.03 (+35.50%)
Jul 2, 2026
17w ago
8-K
BULLISH ★ 6/10
$7.28 $5.92▼ −18.68%▼ −18.27%$11.03 (+51.51%)
Showing 6 of 6

US Market Status

Market Closed · Opens Tue (10h 51m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 29, 2026